Useful resources |
Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease (Cochrane Review) ABSTRACT Background: Chronic obstructive pulmonary disease (COPD) is a condition associated with high morbidity, mortality and cost to the community. Patients often report symptomatic improvement with long acting beta-2 agonists (LABAs) and anticholinergic bronchodilator . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |